Experimental Neurophysiology and Neuropsychology

Jurasova, V., Andel, R., Katonova, A., Veverova, K., Zuntychova, T., Horakova, H., Vyhnalek, M., Kolarova, T., Matoska, V., Blennow, K., & Hort, J. (2024). CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: A cross-sectional analysis. Alzheimers Res. Ther., 16(1), 199. IF₍₂₀₂₃₎ 7.9 (D1)

Zhang, J., Wang, H.-L., Veverová, K., Vyhnálek, M., & Fang, E. F. (2024). Identification and potential clinical applications of novel autophagy/mitophagy proteins in the biofluids of Alzheimer’s disease patients. Ageing Research Reviews, 99, 102378. IF₍₂₀₂₃₎ 12.5 (D1)

Laczó M., Svatkova R., Lerch O., Martinkovic L., Zuntychova T., Nedelska Z., Horakova H., Vyhnalek M., Hort J., Laczó J. (2024). Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer's disease. iScience. 27 (6):109832. IF₍₂₀₂₃₎ 4.6 (Q1)

Čihák M., Horáková H., Vyhnálek M., Veverová K., Matušková V., Laczó J., Hort J., Nikolai T. (2024). Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers. Arch. Clin. Neuropsychol. Epub ahead of print. IF₍₂₀₂₃₎ 2.1 (Q2)

Veverová K., Laczó J., Katonová A., Horáková H., Matušková V., Angelucci F., Laczó M., Nedelská Z., Hort J., Wang H.L., Zhang J., Shi L., Fei Fang E., Vyhnálek M. (2024). Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease. Autophagy. Epub ahead of print.  IF₍₂₀₂₃₎ 14.6 (D1)

Ogurcakova V, Kajsova M, Marusic P, Amlerova J. (2024). Social cognition in Idiopathic generalised epilepsies. Behav Brain Res. IF₍₂₀₂₃₎ 2.6 (Q2)

Jan Chvojka, Natalie Prochazkova, Monika Rehorova, Jan Kudlacek, Salome Kylarova, Michaela Kralikova, Peter Buran, Romana Weissova, Martin Balastik, JohnG.R. Jefferys, Ondrej Novak, Premysl Jiruska (2024). Mouse model of focal cortical dysplasia type II generates a wide spectrum of high-frequency activities. Neurobiology of Disease 190(10):106383. IF 5.1 (Q1)

Natálie Procházková, Minh Thao Nguyenová, Monika Řehořová, Jan Kudláček, Jan Chvojka, Jakub Ziak, Martin Balaštík, Jakub Otáhal, Přemysl Jiruška, Ondřej Novák (2024). NeuroPorator: An open-source, current-limited electroporator for safe in utero gene transfer. Journal of Neuroscience Methods, Volume 406, June 2024, 110126. IP 3,05 (Q2)

Markova H., Fendrych Mazancova A., Jester D.J., Cechova K., Matuskova V., Nikolai T., Nedelska Z., Uller M., Andel R., Laczó J., Hort J., Vyhnalek M. (2023). Memory Binding Test and Its Associations With Hippocampal Volume Across the Cognitive Continuum Preceding Dementia. Assessment. 30 (3): 856-872. IF 3.5 (Q1)

Angelucci, F., Veverova, K., Katonová, A., Vyhnalek, M., & Hort, J. (2024). Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degeneration. Journal of Cellular and Molecular Medicine, 28(5), e18013. IF 4.3 (Q2)

Angelucci, F., Veverova, K., Katonová, A., Vyhnalek, M., & Hort, J. (2023). Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity. ACS Omega, 8(39), 36025–36031. IF 3.7 (Q2)

Čarna M., Novotny J.S., Dragišić N., Slavik H., Sheardova K., Geda Y.E., Vyhnalek M., Laczo J., Hort J., Mao Z., Rissman R.A., Hajduch M., Dammer E.B., Stokin G.B. (2023). Missorting of plasma miRNAs in aging and Alzheimer's disease. J. Neurochem. 165 (2): 149-161. IF 4.2 (Q2)

Čarna M., Onyango I.G., Katina S., Holub D., Novotny J.S., Nezvedova M., Jha D., Nedelska Z., Lacovich V., Vyvere T.V., Houbrechts R., Garcia-Mansfield K., Sharma R., David-Dirgo V., Vyhnalek M., Texlova K., Chaves H., Bakkar N., Pertierra L., Vinkler M., Markova H., Laczo J., Sheardova K., Hortova-Kohoutkova M., Frič J., Forte G., Kaňovsky P., Belaškova S., Damborsky J., Hort J., Seyfried N.T., Bowser R., Sevlever G., Rissman R.A., Smith R.A., Hajduch M., Pirrotte P., Spacil Z., Dammer E.B., Limbäck-Stokin C., Stokin G.B. (2023). Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus. Alzheimers Dement. 19 (8): 3537-3554. IF 13.0 (D1)

Matuskova V., Veverova K., Jester D.J., Matoska V., Ismail Z., Sheardova K., Horakova H., Cerman J., Laczó J., Andel R., Hort J., Vyhnalek M. (2023). Mild behavioural impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms. Alzheimers Res. Ther. 16 (1): 21. IF 7.9 (D1)

Přemysl Jiruška, Dean Freestone, Vadym Gnatkovsky, Yujiang Wang (2023). An update on the seizures beget seizures theory. Epilepsia Official Journal of the International League Against Epilepsy. IP 6,6 (Q1)

Lerch O., Laczó M., Vyhnálek M., Nedelská Z., Hort J., Laczó J. (2022). APOEɛ4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia. J. Alzheimers Dis. 86 (1): 155-171. IF 4.0 (Q2)

Jester D.J., Vyhnálek M., Andel R., Marková H., Nikolai T., Laczó J., Matusková V., Cechová K., Sheardova K., Hort J. (2022). Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance. J. Alzheimers Dis. 86 (4): 1763-1774. IF 4.0 (Q2)

Vyhnalek M., Jester D.J., Andel R., Horakova H., Nikolai T., Laczó J., Matuskova V., Cechova K., Sheardova K., Hort J. (2022). Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia. J. Alzheimers Dis. 88 (4): 1397-1409. IF 4.0 (Q2)

Angelucci, F., Veverova, K., Katonova, A., Piendel, L., Vyhnalek, M., & Hort, J. (2022). Alzheimer’s Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis. Pharmaceuticals, 15(9), 1074. https://doi.org/10.3390/ph15091074 IF 4.6 (Q2)

Bellenguez C., Küçükali F., Jansen IE., Kleineidam L., Moreno-Grau S., Amin N., et al. (2022). New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat. Genet. 54 (4): 412-436. IF 30.8 (D1)

Amlerova J., Laczó J., Nedelska Z., Laczó M., Vyhnálek M., Zhang B., Sheardova K., Angelucci F., Andel R., Hort J. (2022). Emotional prosody recognition is impaired in Alzheimer's disease. Alzheimers. Res. Ther. 14 (1): 50. IF 9.0 (D1)

Laczó M., Martinkovic L., Lerch O., Wiener JM., Kalinova J., Matuskova V., Nedelska Z., Vyhnalek M., Hort J., Laczó J. (2022). Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment. Front. Aging Neurosci. 14: 886778. IF 4.8 (Q2)

Šerý O., Zeman T., Sheardová K., Vyhnálek M., Marková H., Laczó J., Lochman J., Kralik P., Vrzalová K., Dziedzinska R., Balcar V.J., Hort J. (2022). Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease. Sci. Rep. 12 (1): 10994. IF 4.6 (Q2)

Moore M., Milosevich E., Beisteiner R., Bowen A., Checketts M., Demeyere N., Fordell H., Godefroy O., Laczó J., Rich T., Williams L., Woodward-Nutt K., Husain M. (2022). Rapid screening for neglect following stroke: A systematic search and European Academy of Neurology recommendations. Eur. J. Neurol. 29 (9): 2596-2606. IF 5.1 (Q1)

Nemergut M., Batkova T., Vigasova D., Bartos M., Hlozankova M., Schenkmayerova A., Liskova B., Sheardova K., Vyhnalek M., Hort J., Laczó J., Kovacova I., Sitina M., Matej R., Jancalek R., Marek M., Damborsky J. (2022). Increased occurrence of Treponema spp. and double-species infections in patients with Alzheimer's disease. Sci. Total Environ. 844:157114. IF 9.8 (D1)

Nelson M.E., Veal B.M., Andel R., Martinkova J., Veverova K., Horakova H., Nedelska Z., Laczó J., Vyhnalek M., Hort J. (2022). Moderating effect of cognitive reserve on brain integrity and cognitive performance. Front. Aging Neurosci. 14: 1018071. IF 4.8 (Q2)

Němá E., Kalina A., Nikolai T., Vyhnálek M., Meluzínová E., Laczó J. (2021). Spatial navigation in early multiple sclerosis: a neglected cognitive marker of the disease? J. Neurol. 268 (1): 77-89. IF 6.682 (Q1)

Jester D.J., Andel R., Cechová K., Laczó J., Lerch O., Marková H., Nikolai T., Vyhnálek M., Hort J. (2021). Cognitive Phenotypes of Older Adults with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment: The Czech Brain Aging Study. J. Int. Neuropsychol. Soc. 27 (4): 329-342. IF 3.114 (Q3)

Nelson M.E., Andel R., Nedelska Z., Martinkova J., Cechova K., Markova H., Matuskova V., Nikolai T., Lerch O., Parizkova M., Laczo J., Vyhnalek M., Hort J. (2021). The Association Between Homocysteine and Memory in Older Adults. J. Alzheimers Dis. 81 (1): 413-426. IF 4.160 (Q2)

Matuskova V., Ismail Z., Nikolai T., Markova H., Cechova K., Nedelska Z., Laczo J., Wang M., Hort J., Vyhnalek M. (2021). Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort. Front. Aging Neurosci. 13: 643271. IF 5.702 (Q1)

de Rojas I., Moreno-Grau S., Tesi N., Grenier-Boley B., Andrade V., Jansen I.E., et al. (2021). Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nat. Commun. 12 (1): 3417. IF 17.694 (D1)

Gobom J., Parnetti L., Rosa-Neto P., Vyhnalek M., Gauthier S., Cataldi S., Lerch O., Laczo J., Cechova K., Clarin M., Benet AL., Pascoal TA., Rahmouni N., Vandijck M., Huyck E., Le Bastard N., Stevenson J., Chamoun M., Alcolea D., Lleó A., Andreasson U., Verbeek MM., Bellomo G., Rinaldi R., Ashton NJ., Zetterberg H., Sheardova K., Hort J., Blennow K. (2021). Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin. Chem. Lab. Med. 60 (2): 207-219. IF 6.800 (D1)

Laczó M., Wiener J.M., Kalinova J., Matuskova V., Vyhnalek M., Hort J., Laczó J. (2021). Spatial Navigation and Visuospatial Strategies in Typical and Atypical Aging. Brain Sci. 11 (11): 1421. IF 3.333 (Q3)

Laczó M., Lerch O., Martinkovic L., Kalinova J., Markova H., Vyhnalek M., Hort J., Laczó J. (2021). Spatial Pattern Separation Testing Differentiates Alzheimer's Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment. Front. Aging Neurosci. 13: 774600. IF 5.702 (Q1)

Jan Kudlacek, Jan Chvojka, Vojtech Kumpost, Barbora Hermanovska, Antonin Posusta, John G.R. Jefferys, Matias I. Maturana, Ondrej Novak, Mark J. Cook, Jakub Otahal, Jaroslav Hlinka, Premysl Jiruska (2021). Long-term seizure dynamics are determined by the nature of seizures and the mutual interactions between them. Neurobiology of Disease, 24 Mar 2021, 154:105347. IF 5.1 (Q1)

Cechova K., Andel R., Angelucci F., Chmatalova Z., Markova H., Laczó J., Vyhnalek M., Matoska V., Kaplan V., Nedelska Z., Ward D., Hort J. (2020). Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment. J. Alzheimers Dis. 73 (1): 247–257. IF 4.472 (Q2)

Kristofikova Z., Springer T., Gedeonova E., Hofmannova A., Ricny J., Hromadkova L., Vyhnalek M., Laczo J., Nikolai T., Hort J., Petrasek T., Stuchlik A., Vales K., Klaschka J., Homola J. (2020). Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease. Neurochem. Res. 45 (4): 915–927. IF 3.996 (Q2)

Di Nuovo S., De Beni R., Borella E., Marková H., Laczó J., Vyhnálek M. (2020). Cognitive Impairment in Old Age: Is the Shift From Healthy to Pathological Aging Responsive to Prevention?. Eur. Psychol. 25 (3): 174–185. IF 5.569 (Q1)

Parizkova M., Lerch O., Andel R., Kalinova J., Markova H., Vyhnalek M., Hort J., Laczó J. (2020). Spatial Pattern Separation in Early Alzheimer's Disease. J. Alzheimers Dis. 76 (1): 121–138. IF 4.472 (Q2)

Laczó J., Cechova K., Parizkova M., Lerch O., Andel R., Matoska V., Kaplan V., Matuskova V., Nedelska Z., Vyhnalek M., Hort J. (2020). The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults. J. Alzheimers Dis. 78 (4): 1473-1492. IF 4.472 (Q2)

Matias I. Maturana, Christian Meisel, Katrina Dell, Philippa J. Karoly, Wendyl D’Souza, David B. Grayden, Anthony N. Burkitt, Premysl Jiruska, Jan Kudlacek, Jaroslav Hlinka, Mark J. Cook, Levin Kuhlmann & Dean R. Freestone (2020). Critical slowing down as a biomarker for seizure susceptibility. Nature Communications May 202011 (1):2172. IF 14.7 (Q1)

Pappas C., Small B.J., Andel R., Laczó J., Parizkova M., Ondrej L., Hort J. (2019). Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment. J. Alzheimers Dis. 67 (1): 81–89. IF 3.909 (Q2)

Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019). Antibiotics, gut microbiota, and Alzheimer’s disease. Journal of Neuroinflammation, 16(1), 108. https://doi.org/10.1186/s12974-019-1494-4 IF 5.8 (Q1)

Angelucci, F., Cechova, K., Prusa, R., & Hort, J. (2019). Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications. CNS Neuroscience & Therapeutics, 25(3), 303–313. https://doi.org/10.1111/cns.13082 IF 4.1 (Q1)

Angelucci, F., Cechova, K., Valis, M., Kuca, K., Zhang, B., & Hort, J. (2019). MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents? Frontiers in Pharmacology, 10, 665. https://doi.org/10.3389/fphar.2019.00665 IF 4.2 (Q1)

Markova H., Nikolai T., Mazancova A.F., Cechova K., Sheardova K., Georgi H., Kopecek M., Laczó J., Hort J., Vyhnalek M. (2019). Differences in Subjective Cognitive Complaints Between Non-Demented Older Adults from a Memory Clinic and the Community. J. Alzheimers Dis. 70 (1): 61–73. IF 3.909 (Q2)

Vyhnálek M., Marková H., Laczó J., De Beni R., Di Nuovo S. (2019). Assessment of Memory Impairment in Early Diagnosis of Alzheimer's Disease. Curr. Alzheimer Res. 16 (11): 975–985. IF 3.047 (Q2)

Sheardova K., Vyhnalek M., Nedelska Z., Laczo J., Andel R., Marciniak R., Cerman J., Lerch O., Hort J. (2019). Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic. BMJ Open 9 (12): e030379. IF 2.496 (Q2)

J. Chvojka, J. Kudláček, Wei-Chih Chang, O. Novák, Filip Tomaska, J. Otáhal, John Gordon Ralph Jefferys, P. Jiruška (2021). The role of interictal discharges in ictogenesis — A dynamical perspective. Epilepsy and Behavior. Roč. 121, Part B Aug (2021), č. článku 10659, IF: 3.337 (Q2)

Keynejad R.C., Marková H., Šiffelová K., Kumar N., Vlček K., Laczó J., Migo E.M., Hort J., Kopelman M.D. (2018). Spatial navigation deficits in amnestic mild cognitive impairment with neuropsychiatric comorbidity. Neuropsychol. Dev. Cogn. B. Aging Neuropsychol. Cogn. 25 (2): 277‒289. IF 1,845 (Q2)

Chmatalova Z., Vyhnalek M., Laczo J., Hort J., Pospisilova R., Pechova M., Skoumalova A. (2017). Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer's disease. Physiol. Res. 66 (6): 1049‒1056. IF 1,324 (Q4)

Cerman J., Andel R., Laczo J., Vyhnalek M., Nedelska Z., Mokrisova I., Sheardova K., Hort J. (2018). Subjective Spatial Navigation Complaints ‒ A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease. Curr. Alzheimer Res. 15 (3): 219‒228. IF 3,211 (Q2)

Parizkova M., Lerch O., Moffat S.D., Andel R., Mazancova A.F., Nedelska Z., Vyhnalek M., Hort J., Laczó J. (2018). The effect of Alzheimer's disease on spatial navigation strategies. Neurobiol. Aging 64: 107‒115. IF 4,398 (Q1)

Urbanova B.S., Schwabova J.P., Magerova H., Jansky P., Markova H., Vyhnalek M., Laczo J., Hort J., Tomek A. (2018). Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment. J. Alzheimers Dis. 63 (2): 465‒477. IF 3,517 (Q2)

Hyncicova E., Kalina A., Vyhnalek M., Nikolai T., Martinkovic L., Lisy J., Hort J., Meluzinova E., Laczó J. (2018). Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome. PLoS One. 13 (7): e0200254. IF 2,776 (Q2)

Coughlan G., Laczó J., Hort J., Minihane A.M., Hornberger M. (2018). Spatial navigation deficits ‒ overlooked cognitive marker for preclinical Alzheimer disease? Nat. Rev. Neurol. 14 (8): 496‒506. IF 21,155 (D1)

Laczó J., Parizkova M., Moffat S.D. (2018). Spatial navigation, aging and Alzheimer's disease. Aging-US. 10 (11): 3050–3051. IF 5,515 (D1)

Wei-Chih Chang, Jan Kudlacek, Jaroslav Hlinka, Jan Chvojka, Michal Hadrava, Vojtech Kumpost, Andrew D. Powell, Radek Janca, Matias I. Maturana, Philippa J. Karoly, Dean R. Freestone, Mark J. Cook, Milan Palus, Jakub Otahal, John G. R. Jefferys & Premysl Jiruska (2018). Loss of neuronal network resilience precedes seizures and determines the ictogenic nature of interictal synaptic perturbations. Nature Neuroscience volume 21, 1742–1752. IF 14.7 (Q1)

Chang WC, Kudlacek J, Hlinka J, Chvojka J, Hadrava M, Kumpost V, Powell AD, Janca R, Maturana MI, Karoly PJ, Freestone DR, Cook MJ, Palus M, Otahal J, Jefferys JGR, Jiruska P (2018). Loss of neuronal network resilience precedes seizures and determines the ictogenic nature of interictal synaptic perturbations. Nat Neurosci 2018 Dec;21(12):1742-1752. IF 14.7 (Q1)

Vyhnálek M., Rubínová E., Marková H., Nikolai T., Laczó J., Andel R., Hort J. (2017). Clock drawing test in screening for Alzheimer's dementia and mild cognitive impairment in clinical practice. Int. J. Geriatr. Psychiatry 32 (9): 933‒939. IF 2,940 (Q1)

Pařízková M., Andel R., Lerch O., Marková H., Gažová I., Vyhnálek M., Hort J., Laczó J. (2017). Homocysteine and Real-Space Navigation Performance among Non-Demented Older Adults. J. Alzheimers Dis. 55 (3): 951‒964. IF 3,476 (Q2)

Laczó J., Markova H., Lobellova V., Gazova I., Parizkova M., Cerman J., Nekovarova T., Vales K., Klovrzova S., Harrison J., Windisch M., Vlcek K., Svoboda J., Hort J., Stuchlik A. (2017). Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans. Psychopharmacology (Berl) 234 (4): 535‒547. IF 3,222 (Q2)

Hynčicová E., Vyhnálek M., Kalina A., Martinkovič L., Nikolai T., Lisý J., Hort J., Meluzínová E., Laczó J. (2017). Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis. J. Neurol. 264 (3): 482‒493. IF 3,783 (Q1)

Chmátalová Z., Vyhnálek M., Laczó J., Hort J., Skoumalová A. (2016). Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients. J. Cell. Mol. Med. 20 (7): 1367‒1372. IF 4,499 (Q1)

Mokrisova I., Laczo J., Andel R., Gazova I., Vyhnalek M., Nedelska Z., Levcik D., Cerman J., Vlcek K., Hort J. (2016). Real-space path integration is impaired in Alzheimer's disease and mild cognitive impairment. Behav. Brain Res. 1 (307): 150‒158. IF 3,002 (Q2)

Marková H., Laczó J., Andel R., Hort J., Vlček K. (2015). Perspective taking abilities in amnestic mild cognitive impairment and Alzheimer’s disease. Behav. Brain. Res. 281: 229‒238. IF 3,002 (Q2)

Vyhnalek M., Magerova H., Andel R., Nikolai T., Kadlecova A., Laczo J., Hort J. (2015). Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates. J. Neurol. Sci. 349: 179‒184. IF 2,126 (Q3)

Schmidt R., Hofer E., Bouwman F.H., Buerger K., Cordonnier C., Fladby T., Galimberti D., Georges J., Heneka M.T., Hort J, Laczó J., Molinuevo J.L., O'Brien J.T., Religa D., Scheltens P., Schott J.M., Sorbi S. (2015). EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur. J. Neurol. 22 (6): 889‒898. IF 3,956 (Q1)

Chanti-Ketterl M., Andel R., Lerch O., Laczo J., Hort J. (2015). Cholesterol and cognitive performance among community volunteers from the Czech Republic. Int. Psychogeriatr. 27 (12): 2087‒2095. IF 2,220 (Q2)

Laczó J., Andel R., Vyhnalek M., Matoska V., Kaplan V., Nedelska Z., Lerch O., Gazova I., Moffat S.D., Hort J. (2015). The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment. Neurobiol. Aging 36 (6): 2024‒2033. IF 5,153 (D1)

Kristofikova Z., Ricny J., Vyhnalek M., Hort J., Laczo J., Sirova J., Klaschka J., Ripova D. (2015). Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias. J. Alzheimers Dis. 48 (1): 105‒114. IF 3,920 (Q2)

Kerbler G.M., Nedelska Z., Fripp J., Laczó J., Vyhnalek M., Lisý J., Hamlin A.S., Rose S., Hort J., Coulson E.J. (2015). Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer's Disease Patients. Front. Aging Neurosci.7: 185. IF 4,348 (Q1)

Hort J., Andel R., Mokrisova I., Gazova I., Amlerova J., Valis M., Coulson E.J., Harrison J., Windisch M., Laczó J. (2014). Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris Water Maze. Neurodegenerative Dis. 13 (2‒3): 192‒196. IF 3,511 (Q1)

Vlček K., Laczó J. (2014). Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer’s disease. Front. Behav. Neurosci. 8: 89. IF 3,270 (Q1)

Schwabova J., Maly T., Laczó J., Zumrova A., Komarek V., Musova Z., Zahalka F. (2014). Application of a Scale for the Assessment and Rating of Ataxia (SARA) in Friedreich's ataxia patients according to posturography is limited. J. Neurol. Sci. 341 (1‒2): 64‒67. IF 2,474 (Q2)

Kristofikova Z., Ricny J., Kolarova M., Vyhnalek M., Hort J., Laczo J., Sirova J., Ripova D. (2014). Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease. J. Alzheimers Dis. 42 (Suppl. 3): 91‒98. IF 4,151 (Q1)

Vyhnalek M., Nikolai T., Andel R., Nedelska Z., Rubínová E., Marková H., Laczó J., Bezdicek O., Sheardova K., Hort J. (2014). Neuropsychological Correlates of Hippocampal Atrophy in Memory Testing in Nondemented Older Adults. J. Alzheimers Dis. 42 (Suppl. 3): 81‒90. IF 4,151 (Q1)

Laczó J., Andel R., Vyhnalek M., Vlcek K., Nedelska Z., Matoska V., Gazova I., Mokrisova I., Sheardova K., Hort J. (2014). APOE and spatial navigation in amnestic MCI: Results from a computer-based test. Neuropsychology 28 (5): 676‒684. IF 3,269 (Q1)

Magerova H., Vyhnalek M., Laczo J., Andel R., Rektorova I., Kadlecova A., Bojar M., Hort J. (2014). Odor Identification in Frontotemporal Lobar Degeneration Subtypes. Am. J. Alzheimers Dis. Other Demen. Magerova H., Vyhnalek M., Laczo J., Andel R., Rektorova I., Kadlecova A., Bojar M., Hort J. (2014). Odor Identification in Frontotemporal Lobar Degeneration Subtypes. Am. J. Alzheimers Dis. Other Demen. 29 (8): 762‒768. IF 1,627 (Q3)

Sheardova K., Laczó J., Vyhnalek M., Andel R., Mokrisova I., Vlcek K., Amlerova J., Hort J. (2014). Famous landmark identification in amnestic mild cognitive impairment and Alzheimer's disease. PLoS One 9 (8): e105623. IF 3,234 (Q1)

Rubínová E., Nikolai T., Marková H., Šiffelová K., Laczó J., Hort J., Vyhnálek M. (2014). Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: Can more detailed scoring systems do the work? J. Clin. Exp. Neuropsychol. 36 (10): 1076‒1083. IF 2,083 (Q2)

Varjassyová A., Hořínek D., Andel R., Amlerova J., Laczó J., Sheardová K., Magerová H., Holmerová I., Vyhnálek M., Bradáč O., Geda YE., Hort J. (2013). Recognition of facial emotional expression in amnestic mild cognitive impairment. J. Alzheimers Dis. 33 (1): 273‒280. IF 3,612 (Q2)

Amlerova J., Laczó J., Vlcek K., Javurkova A., Andel R., Marusic P. (2013). Risk factors for spatial memory impairment in patients with temporal lobe epilepsy. Epilepsy Behav. 26 (1): 57‒60. IF 2,061 (Q3)

Gazova I., Laczó J., Rubinova E., Mokrisova I., Hyncicova E., Andel R., Vyhnalek M., Sheardova K., Coulson E.J.,  Hort J. (2013). Spatial navigation in young versus older adults. Front. Aging Neurosci. 5: 94. IF 2,843 (Q2)

Laczó J., Andel R., Vyhnalek M., Vlcek K., Magerova H., Varjassyova A., Nedelska Z., Gažova I., Bojar M., Sheardova K., Hort J. (2012). From Morris Water Maze to computer tests in the prediction of Alzheimer´s disease. Neurodegenerative Dis. 10 (1‒4): 153‒157. IF 3,410 (Q1)

Nedelska Z., Andel R., Laczó J., Vlcek K., Horinek D., Lisy J., Sheardova K., Bures J., Hort J. (2012). Spatial navigation impairment is proportional to right hippocampal volume. Proc. Natl. Acad. Sci. U.S.A. 109 (7): 2590‒2594. IF 9,737 (D1)

Majerová V., Kalinčík T., Laczó J., Vyhnálek M., Hort J., Bojar M., Růžička E., Roth J. (2012). Disturbance of real space navigation in moderately advanced but not in early Huntington's disease. J. Neurol. Sci. 312 (1‒2): 86‒91. IF 2,243 (Q2)

Gazova I., Vlcek K., Laczó J., Nedelska Z., Hyncicova E., Mokrisova I., Sheardova K., Hort J. (2012). Spatial navigation‒a unique window into physiological and pathological aging. Front. Aging Neurosci. 4: 16. IF 5,224 (D1)

Stěpán-Buksakowska I., Keller J., Laczó J., Rulseh A., Hort J., Lisý J., Charvát F., Roček M., Hořínek D. (2012). Diffusion tensor imaging in Alzheimer disease and mild cognitive impairment. Neurol. Neurochir. Pol. 46 (5): 462‒471. IF 0,486 (Q4)

Laczó J., Andel R., Vlček K., Macoška V., Vyhnálek M., Tolar M., Bojar M., Hort J. (2011). Spatial navigation and APOE in amnestic mild cognitive impairment. Neurodegenerative Dis. 8 (4): 169‒177. IF 3,056 (Q2)

Ritchie C.W., Ames D., Burke J.R., Bustin J., Connelly P., Laczó J., Portet F. (2011). An international perspective on advanced neuroimaging: cometh the hour or ivory tower? Int. Psychogeriatr. 23 (Suppl. 2): 58‒64. IF 2,240 (Q2)

Laczó J., Andel R., Vyhnalek M., Vlcek K., Magerova H., Varjassyova A., Tolar M., Hort J. (2010). Human analogue of the Morris water maze for testing subjects at risk of Alzheimer's disease. Neurodegenerative Dis. 7 (1‒3): 148‒152. IF 3,791 (Q1)

Laczó J., Vlček K., Vyhnálek M., Vajnerová O., Ort M., Holmerová I., Tolar M., Andel R., Bojar M., Hort J. (2009). Spatial navigation testing discriminates two types of amnestic mild cognitive impairment. Behav. Brain. Res. 202 (2): 252‒259. IF 3,220 (Q2)

–

Hort J., Laczó J., Vyhnálek M., Bojar M., Bureš J., Vlček K. (2007). Spatial navigation deficit in amnestic Mild cognitive impairment. Proc. Natl. Acad. Sci. U.S.A. 104 (10): 4042‒4047. IF 9,598 (D1)